When it comes to why people jump ship to a new job, a fatter paycheck often steals the spotlight. But dig a little deeper, and it’s clear that […] ...

PE-backed specialty pharma company Kelso Pharma appointed Giovanni Mauri as general manager of its recently acquired Italian ...

Colleges and teaching hospitals are the cornerstones of the city’s economy — and identity. But federal funding cuts to higher ...

A biotech market that initially showed signs of optimism after the election of the second Trump administration is now reeling ...

Biogen on Wednesday said BIIB080 is the first tau-targeting antisense oligonucleotide therapy to enter clinical development for Alzheimer's disease and that it is currently being evaluated in a global ...

The Business Journal found 21 Massachusetts life sciences companies announced layoffs impacting at least 1,000 employees ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

A new survey by Careerminds, a global outplacement and career development firm, found that benefits like retirement ...

Biogen has unveiled plans to open a new global headquarters and innovation hub in Massachusetts, US. The company has signed a 15-year lease for an office and research and development (R&D) space at ...

Kisunla, along with two approved Alzheimer’s therapies from partners Biogen and Eisai, is part of a class of drugs that can also cause side effects like swelling and small-scale bleeding in the brain.

Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of ...